Background Though generally a mild affliction, allergic rhinitis (AR) is very common and
causes considerable discomfort. Ephedra sinica polysaccharide is a candidate cost-effective …

Abstract Background MicroRNA (miR)‐146a, as an important immune regulatory factor with
an anti‐inflammatory effect, plays a crucial role in regulatory T‐cell (Tregs) differentiation …

Background: Allergic rhinitis (AR) is regarded as one of the most common allergic disease of
nasal mucosa affecting many people worldwide. Long noncoding RNAs are critical …

Introduction: Allergic rhinitis (AR) is identified as a multifactorial disease caused by the
interaction of genes and surroundings, which is difficult to cure. MicroRNAs were reported to …

Background Our previous study showed that miR-146a-3p was elevated in serum exosomes
of allergic rhinitis (AR) patients, but the underlying mechanisms were unclarified. This study …

Background Allergic rhinitis (AR) is a chronic inflammatory disease of the nasal mucosa that
is mediated by immunoglobulin E (IgE). Xiao-qing-long-tang (XQLT) is a traditional Chinese …

Background and objectives miRNAs play a crucial role in regulating immune responses.
However, the effect of miR-124-3p on type 2 inflammation in allergic rhinitis (AR) is unclear …

Aim: This study aims to investigate whether microRNA (miR)-146a exerts therapeutic
potential to allergic rhinitis (AR). Methods: Female BALB/c mice were randomly divided into …

Background. Allergic rhinitis (AR) is a global disease without specific treatment. Human
mesenchymal stem cell‐(HMSC‐) derived exosomes (HMSC‐exos) have been implicated …

Background Allergic rhinitis (AR) is regarded as a prevalent and non-infectious inflammation
in nasal mucosa, and astragalus polysaccharide (APS) could mitigate inflammation …